Our Priorities
We focus on developing investigational agents with the ultimate goal of helping advanced cancer patients, especially those with malignant brain tumors, live longer, better lives. The medical need is enormous. We strive to meet these unmet needs through excellence in science and through treatment of patients in FDA-reviewed and Institutional Review Board (IRB) approved clinical trials. We embrace the challenge of well-conduced and scientifically rigorous clinical trials because we are inspired by the possibility of making important differences in the lives of cancer patients around the world.
|
